|
1
|
Field JK, Chen Y, Marcus MW, Mcronald FE,
Raji OY and Duffy SW: The contribution of risk prediction models to
early detection of lung cancer. J Surg Oncol. 108:304–311. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bach PB, Kattan MW, Thornquist MD, Kris
MG, Tate RC, Barnett MJ, Hsieh LJ and Begg CB: Variations in lung
cancer risk among smokers. J Natl Cancer Inst. 95:470–478. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cassidy A, Myles JP, van Tongeren M, Page
RD, Liloglou T, Duffy SW and Field JK: The LLP risk model: An
individual risk prediction model for lung cancer. Br J Cancer.
98:270–276. 2008. View Article : Google Scholar
|
|
4
|
Hoggart C, Brennan P, Tjonneland A, Vogel
U, Overvad K, Østergaard JN, Kaaks R, Canzian F, Boeing H, Steffen
A, et al: A risk model for lung cancer incidence. Cancer Prev Res
(Phila). 5:834–846. 2012. View Article : Google Scholar
|
|
5
|
Park S, Nam BH, Yang HR, Lee JA, Lim H,
Han JT, Park IS, Shin HR and Lee JS: Individualized risk prediction
model for lung cancer in Korean men. PLoS One. 8:e548232013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Spitz MR, Hong WK, Amos CI, Wu X, Schabath
MB, Dong Q, Shete S and Etzel CJ: A risk model for prediction of
lung cancer. J Natl Cancer Inst. 99:715–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tammemagi CM, Pinsky PF, Caporaso NE,
Kvale PA, Hocking WG, Church TR, Riley TL, Commins J, Oken MM, Berg
CD, et al: Lung cancer risk prediction: Prostate, Lung, Colorectal
and Ovarian Cancer Screening Trial models and validation. J Natl
Cancer Inst. 103:1058–1068. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Young RP and Hopkins RJ: Incorporating
genomic data into multivariate risk models for lung cancer. Genet
Med. 15:667–668. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H, Yang L, Zhao X, Wang J, Qian J, Chen
H, Fan W, Liu H, Jin L, Wang W, et al: Prediction of lung cancer
risk in a Chinese population using a multifactorial genetic model.
BMC Med Genet. 13:1182012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Raji OY, Agbaje OF, Duffy SW, Cassidy A
and Field JK: Incorporation of a genetic factor into an
epidemiologic model for prediction of individual risk of lung
cancer: The Liverpool Lung Project. Cancer Prev Res (Phila).
3:664–669. 2010. View Article : Google Scholar
|
|
11
|
Spitz MR, Etzel CJ, Dong Q, Amos CI, Wei
Q, Wu X and Hong WK: An expanded risk prediction model for lung
cancer. Cancer Prev Res (Phila). 1:250–254. 2008. View Article : Google Scholar
|
|
12
|
Beane J, Sebastiani P, Whitfield TH,
Steiling K, Dumas YM, Lenburg ME and Spira A: A prediction model
for lung cancer diagnosis that integrates genomic and clinical
features. Cancer Prev Res (Phila). 1:56–64. 2008. View Article : Google Scholar
|
|
13
|
Young RP, Hopkins RJ, Whittington CF, Hay
BA, Epton MJ and Gamble GD: Individual and cumulative effects of
GWAS susceptibility loci in lung cancer: Associations after
sub-phenotyping for COPD. PLoS One. 6:e164762011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hung RJ, McKay JD, Gaborieau V, Boffetta
P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N,
Lissowska J, Rudnai P, et al: A susceptibility locus for lung
cancer maps to nicotinic acetylcholine receptor subunit genes on
15q25. Nature. 452:633–637. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Truong T, Hung RJ, Amos CI, Wu X,
Bickeböller H, Rosenberger A, Sauter W, Illig T, Wichmann HE, Risch
A, et al: Replication of lung cancer susceptibility loci at
chromosomes 15q25, 5p15, and 6p21: A pooled analysis from the
International Lung Cancer Consortium. J Natl Cancer Inst.
102:959–971. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hosgood HD III, Menashe I, Shen M, Yeager
M, Yuenger J, Rajaraman P, He X, Chatterjee N, Caporaso NE, Zhu Y,
et al: Pathway-based evaluation of 380 candidate genes and lung
cancer susceptibility suggests the importance of the cell cycle
pathway. Carcinogenesis. 29:1938–1943. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu G, Gramling S, Munoz D, Cheng D, Azad
AK, Mirshams M, Chen Z, Xu W, Roberts H, Shepherd FA, et al: Two
novel BRM insertion promoter sequence variants are associated with
loss of BRM expression and lung cancer risk. Oncogene.
30:3295–3304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gail MH: Discriminatory accuracy from
single-nucleotide polymorphisms in models to predict breast cancer
risk. J Natl Cancer Inst. 100:1037–1041. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Spitz MR, Amos CI, D'Amelio A Jr, Dong Q
and Etzel C: Re: Discriminatory accuracy from single-nucleotide
polymorphisms in models to predict breast cancer risk. J Natl
Cancer Inst. 101:1731–1732. 2009.author reply 1732. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei Z, Sun W, Wang K and Hakonarson H:
Multiple testing in genome-wide association studies via hidden
Markov models. Bioinformatics. 25:2802–2808. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moore JH and Williams SM: Epistasis and
its implications for personal genetics. Am J Hum Genet. 85:309–320.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan Q, Hu T and Moore JH: Epistasis,
complexity, and multi-factor dimensionality reduction. Methods Mol
Biol. 1019:465–477. 2013. View Article : Google Scholar
|
|
23
|
Hanley JA and McNeil BJ: The meaning and
use of the area under a receiver operating characteristic (ROC)
curve. Radiology. 143:29–36. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pencina MJ, D'Agostino RB Sr, D'Agostino
RB Jr and Vasan RS: Evaluating the added predictive ability of a
new marker: from area under the ROC curve to reclassification and
beyond. Stat Med. 27:157–172. 2008. View
Article : Google Scholar
|
|
25
|
Leening MJ, Vedder MM, Witteman JC,
Pencina MJ and Steyerberg EW: Net reclassification improvement:
computation, interpretation, and controversies: a literature review
and clinician's guide. Ann Intern Med. 160:122–131. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Young RP, Hopkins RJ, Hay BA, Epton MJ,
Mills GD, Black PN, Gardner HD, Sullivan R and Gamble GD: Lung
cancer susceptibility model based on age, family history and
genetic variants. PLoS One. 4:e53022009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Raji OY, Duffy SW, Agbaje OF, Baker SG,
Christiani DC, Cassidy A and Field JK: Predictive accuracy of the
Liverpool Lung Project risk model for stratifying patients for
computed tomography screening for lung cancer: A case-control and
cohort validation study. Ann Intern Med. 157:242–250. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hahn LW, Ritchie MD and Moore JH:
Multifactor dimensionality reduction software for detecting
gene-gene and gene-environment interactions. Bioinformatics.
19:376–382. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moore JH, Gilbert JC, Tsai CT, Chiang FT,
Holden T, Barney N and White BC: A flexible computational framework
for detecting, characterizing, and interpreting statistical
patterns of epistasis in genetic studies of human disease
susceptibility. J Theor Biol. 241:252–261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Motsinger AA and Ritchie MD: The effect of
reduction in cross-validation intervals on the performance of
multifactor dimensionality reduction. Genet Epidemiol. 30:546–555.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cordell HJ: Detecting gene-gene
interactions that underlie human diseases. Nat Rev Genet.
10:392–404. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang H, Wang M and Chen X: Willows: A
memory efficient tree and forest construction package. BMC
Bioinformatics. 10:1302009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bureau A, Dupuis J, Falls K, Lunetta KL,
Hayward B, Keith TP and Van Eerdewegh P: Identifying SNPs
predictive of phenotype using random forests. Genet Epidemiol.
28:171–182. 2005. View Article : Google Scholar
|
|
34
|
Chen X, Wang M and Zhang H: The use of
classification trees for bioinformatics. Wiley Interdiscip Rev Data
Min Knowl Discov. 1:55–63. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
DeLong ER, DeLong DM and Clarke-Pearson
DL: Comparing the areas under two or more correlated receiver
operating characteristic curves: A nonparametric approach.
Biometrics. 44:837–845. 1988. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Steyerberg EW, Harrell FE Jr, Borsboom GJ,
Eijkemans MJ, Vergouwe Y and Habbema JD: Internal validation of
predictive models: Efficiency of some procedures for logistic
regression analysis. J Clin Epidemiol. 54:774–781. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cook NR: Use and misuse of the receiver
operating characteristic curve in risk prediction. Circulation.
115:928–935. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu CQ, Popova SN, Brown ER,
Barsyte-Lovejoy D, Navab R, Shih W, Li M, Lu M, Jurisica I, Penn
LZ, et al: Integrin alpha 11 regulates IGF2 expression in
fibroblasts to enhance tumorigenicity of human non-small-cell lung
cancer cells. Proc Natl Acad Sci USA. 104:11754–11759. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bhowmick NA, Chytil A, Plieth D, Gorska
AE, Dumont N, Shappell S, Washington MK, Neilson EG and Moses HL:
TGF-beta signaling in fibroblasts modulates the oncogenic potential
of adjacent epithelia. Science. 303:848–851. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gleave M, Hsieh JT, Gao CA, von Eschenbach
AC and Chung LW: Acceleration of human prostate cancer growth in
vivo by factors produced by prostate and bone fibroblasts. Cancer
Res. 51:3753–3761. 1991.PubMed/NCBI
|
|
41
|
Mueller MM and Fusenig NE: Friends or foes
- bipolar effects of the tumour stroma in cancer. Nat Rev Cancer.
4:839–849. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang KK, Liu N, Radulovich N, Wigle DA,
Johnston MR, Shepherd FA, Minden MD and Tsao MS: Novel candidate
tumor marker genes for lung adenocarcinoma. Oncogene. 21:7598–7604.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dinarello CA: IL-18: A TH1-inducing,
proinflammatory cytokine and new member of the IL-1 family. J
Allergy Clin Immunol. 103:11–24. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kojima H, Aizawa Y, Yanai Y, Nagaoka K,
Takeuchi M, Ohta T, Ikegami H, Ikeda M and Kurimoto M: An essential
role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1
cells. J Immunol. 162:5063–5069. 1999.PubMed/NCBI
|
|
45
|
Rovina N, Hillas G, Dima E, Vlastos F,
Loukides S, Veldekis D, Roussos C, Alhanatis M and Bakakos P: VEGF
and IL-18 in induced sputum of lung cancer patients. Cytokine.
54:277–281. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Farjadfar A, Mojtahedi Z, Ghayumi MA,
Erfani N, Haghshenas MR and Ghaderi A: Interleukin-18 promoter
polymorphism is associated with lung cancer: A case-control study.
Acta Oncol. 48:971–976. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nakanishi K, Yoshimoto T, Tsutsui H and
Okamura H: Interleukin-18 is a unique cytokine that stimulates both
Th1 and Th2 responses depending on its cytokine milieu. Cytokine
Growth Factor Rev. 12:53–72. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Okano F and Yamada K: Canine
interleukin-18 induces apoptosis and enhances Fas ligand mRNA
expression in a canine carcinoma cell line. Anticancer Res.
20:3411–3415. 2000.PubMed/NCBI
|
|
49
|
Hammerman PS, Sos ML, Ramos AH, Xu C, Dutt
A, Zhou W, Brace LE, Woods BA, Lin W, Zhang J, et al: Mutations in
the DDR2 kinase gene identify a novel therapeutic target in
squamous cell lung cancer. Cancer Discov. 1:78–89. 2011. View Article : Google Scholar
|
|
50
|
Ford CE, Lau SK, Zhu CQ, Andersson T, Tsao
MS and Vogel WF: Expression and mutation analysis of the discoidin
domain receptors 1 and 2 in non-small cell lung carcinoma. Br J
Cancer. 96:808–814. 2007. View Article : Google Scholar : PubMed/NCBI
|
